Skip to main content
SpringerLink
Log in

The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Ro 15-1788 is an imidazodiazepine which was initially described as a pure benzodiazepine antagonist lacking in intrinsic actions. Although recent animal work has shown the drug to have differing intrinsic actions depending on the dose, the majority of studies on human subjects conclude that it is a pure antagonist of benzodiazepines. Two oral doses of Ro 15-1788 (30 mg and 100 mg) were compared with 5 mg diazepam and placebo in their intrinsic effects on a range of psychophysiological, performance and subjective measures in 12 healthy adult subjects. At both these doses Ro 15-1788 showed a mixture of agonist (benzodiazepine-like) effects and other non-benzodiazepine-like effects on the variables measured. Although there was no clear-cut dose-response relationship, the results suggested a predominance of benzodiazepine-like effects at the higher dose on physiological measures whilst the lower dose was observed to have greater effects on a number of behavioural and subjective dimensions. The subjective changes were the opposite of those normally found for benzodiazepines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ashton CH (1985) Benzodiazepine overdose: are specific antagonists useful? Br Med J 290:805–806

    Article  CAS  Google Scholar 

  • Ban TA, Prakash R (1983) Anxiolytics: clinical perspectives. In: Malick JB, Enna SJ, Yamamura HI (eds) Anxiolytics: neurochemical, behavioral and clinical and perspectives. Raven Press, New York

    Google Scholar 

  • Bond A, Lader M (1974) The use of analogue scales in rating subjective feedings. Br J Med Psychol 47:211–218

    Google Scholar 

  • Bond A, Lader M (1981) Comparative effects of diazepam and buspirone on subjective feedings, psychological tests and the EEG. Int Pharmacopsychiatr 16:212–220

    CAS  Google Scholar 

  • Bond A, Lader M (1982) A comparison of the psychotropic profiles of tofisopam and diazepam. Eur J Clin Pharmacol 22:137–142

    Article  CAS  PubMed  Google Scholar 

  • Braestrup C, Honore T, Nielsen M, Petersen EN, Jensen LH (1983) Benzodiazepine receptor ligands with negative efficacy: chloride channel coupling. In: Biggio C, Costa E (eds) Benzodiazepine recognition site ligands: biochemistry and pharmacology, Raven Press, New York, pp. 29–36

    Google Scholar 

  • Crawley JN, Skolnick P, Paul SM (1984) Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse. Neuropharmacology 23:531–537

    Article  CAS  PubMed  Google Scholar 

  • Dantzer R, Perio A (1982) Behavioural evidence for partial agonist property of Ro 15-1788, a benzodiazepine receptor antagonist. Eur J Pharmacol 81:655–658

    Article  CAS  PubMed  Google Scholar 

  • Darragh A, Lambe R, Scully M, Brick I, O'Boyle C, Downie NW (1981) Investigation in man of the efficacy of a benzodiazepine, antagonist, Ro 15-1788, Lancet July 4:8–10

    Article  Google Scholar 

  • Darragh A, Lambe R, Kenny M, Brick I, O'Boyle C (1982a) Ro 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability. Br J Clin Pharmacol 14:677–682

    CAS  PubMed  Google Scholar 

  • Darragh A, Lambe R, Brick I, O'Boyle C (1982b) Antagonism of the central effects of 3-methylclonazepam. Br J Clin Pharmacol 14:871–872

    CAS  PubMed  Google Scholar 

  • Darragh A, Lambe R, O'Boyle C, Kenny M, Brick I (1983) Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788. Psychopharmacology 80:192–195

    Article  CAS  PubMed  Google Scholar 

  • Enrich HM, Sonderegger P, Mai N (1984) Actioon of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal. Neurosci Lett 47:369–373

    Article  Google Scholar 

  • File SE, Lister RG, Nutt DJ (1982) The anxiogenic action of benzodiazepine antagonists. Neuropharmacology 21:1033–1037

    Article  CAS  PubMed  Google Scholar 

  • Fink M (1981) Classification of psychoactive drugs: quantitative EEG analysis in man. In: Van Praag HM, Lader MH, Rafaelsen OJ, Sachar EJ (eds) Handbook of biological psychiatry, Part VI Practical applications of psychotropic drugs and the biological treatments Marcel Dekker, Inc New York and Basel

    Google Scholar 

  • Gaillard JM, Blois R (1983) Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes. Br J Clin Pharmacol 15:529–536

    CAS  PubMed  Google Scholar 

  • Gath I, Wiedenfeld J, Collins GI, Hadad H (1984) Electrophysiological aspects of benzodiazepine antagonists Ro 15-1788 and Ro 15-3505. Br J Clin Pharmacol 18:541–754

    CAS  PubMed  Google Scholar 

  • Golombok S, Lader M (1984) The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects. Br J Clin Pharmacol 18:127–133

    CAS  PubMed  Google Scholar 

  • Greksch G, Prado de Carvalho L, Venault P, Chapouthier G, Rossier J (1983) Convulsions induced by a submaximal dose of pentyleneleatrazol in mice are antagonised by the benzodiazepine antagonist, Ro 15-1788. Life Sci 32:2579–2584

    Article  Google Scholar 

  • Grey S, Sartory G, Rachman S (1979) Synchronous and desynchronous changes during fear reduction. Behav Res Ther 17:137–148

    Article  CAS  PubMed  Google Scholar 

  • Hunkeler W, Mohler H, Pieri L, Pole P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516

    Article  CAS  PubMed  Google Scholar 

  • Insel TR, Siever LJ (1981) The dopamine system challenge in affective disorder: A review of behavioural and neuroendocrine responses. J Clin Psychopharmacol 1:207–213

    Article  CAS  PubMed  Google Scholar 

  • Ismail S, Bonetti EP, Ferro A, Hunkeler W, Kapp W, Timm U (1981) The investigational drug brochure — benzodiazepine antagonist Ro 15-1788. Roche report No. 77'177

  • Itil RM, Schneider SJ, Frederickson JW (1981) The replicability of the psychophysiological effects of diazepam. Biol Psychiatry 16:65–73

    CAS  PubMed  Google Scholar 

  • Jaffe JH, Clovet DH (1981) Opioid dependence: Links between biochemistry and behaviour. In: Van Praag HM, Lader MH, Rafaelsen OJ, Sachar EJ (eds) Handbook of biological psychiatry, part IV: Brain mechanisms and abnormal behaviour chemistry. Marcel Dekker, Inc, New York

    Google Scholar 

  • Karniol IG, Dalton J, Lader M (1976) Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects. Curr Ther Res 20:337–347

    CAS  PubMed  Google Scholar 

  • Klotz U, Ziegler G, Reimann IW (1984) Short communications: Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol 27:115–117

    CAS  PubMed  Google Scholar 

  • Lader M (1983) Benzodiazepine withdrawal states. In: Trimble MR (ed) Benzodiazepines divided. Chichester, Wiley

    Google Scholar 

  • Lang P (1977) Physiological assessment of anxiety and fear. In: Cone J, Hawkins R (eds) Behavioural assessment. Brunner/Mazel, New York, pp 179–195

    Google Scholar 

  • Laurian S, Gaillard JM, Le PK, Schopf J (;1984) Effects of a benzodiazepine antagonist on the diazepam-induced electrical brain activity modifications. Neuropsychobiology 11:55–58

    Google Scholar 

  • Lupolover Y, Safran AB, Desangles D, de Weisse C, Meyer JJ, Bousquet A, Assimacopoulos A (1984) Evaluation of visual function in healthy subjects after administration of Ro 15-1788. Eur J Clin Pharmacol 27:505–507

    Article  CAS  PubMed  Google Scholar 

  • Mohler H, Richards JG (1981) Agonist and antagonist benzodiazepine receptor interaction in vitro.

  • Nutt DJ, Cowen PJ, Little HJ (1982) Unusual interactions of benzodiazepine receptor antagonists. Nature 295:436–438

    Article  CAS  PubMed  Google Scholar 

  • O'Boyle C, Lambe R, Darragh A, Taffe W, Brick I, Kenny M (1983) Ro 15-1788 antagonises the effects of diazepam in man without affecting its bioavailability. Br J Anaesth 55:349–356

    PubMed  Google Scholar 

  • Pellow S, File SE (1984) Review: multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations. Psychopharmacology 83:304–315

    Article  CAS  PubMed  Google Scholar 

  • Petursson H (1982) Clinical and laboratory studies of withdrawal from long-term benzodiazepine treatment. Ph D Thesis, University of London

  • Pole P, Laurent JP, Scherschlicht R, Haefely W (1981) Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788

  • Rosenberg HC, Chiu TH (1985) Blood pressure response to Ro 15-1788, a benzodiazepine antagonist. Life Sci 36:781–787

    Article  CAS  PubMed  Google Scholar 

  • Saletu B, Grünberger J, Linzmeyer L, Fleser R (1980) Anxiolytics and beta-blockers: Evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables. Agressologie 22:5–9

    Google Scholar 

  • Schachter S, Singer J (1962) Cognitive, social and physiological determinants of emotional state. Psychol Rev 69:379–399

    CAS  PubMed  Google Scholar 

  • Schöpf J, Laurian S, Le PK, Gaillard JM (1984) Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: An electrophysiological investigation. Pharmacopsychiatry 17:79–83

    Article  PubMed  Google Scholar 

  • Tyrer PJ (1982) Antianxiety drugs. In: Tyrer PJ (ed) Drugs in psychiatric practice. London, Butterworth

    Google Scholar 

  • Williams FJ (1949) Experimental designs balanced for the estimation of residual effects of treatments. Aust J Sci Res 2:149–168

    Google Scholar 

  • Ziegler WH, Schalch E (1983) Antagonism of benzodiazepine-induced sedation in man. Sleep 1982, 6th Eur Congr Sleep Res, Zurich 1982, pp 427–429

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Institute of Psychiatry, De Crespigny Park, SE5 8AF, London, UK

    Anna Higgitt & Malcolm Lader

  2. Department of Psychology, University College, London, UK

    Peter Fonagy

Authors
  1. Anna Higgitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malcolm Lader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Fonagy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higgitt, A., Lader, M. & Fonagy, P. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology 89, 395–403 (1986). https://doi.org/10.1007/BF02412110

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02412110

Key words

Search

Navigation